英文互译镜像站

Paul Hudson (businessman)

Last updated

Paul Hudson
Paul Hudson Sanofi.jpg
Hudson in 2023
Born(1967-10-14)14 October 1967 [1]
Education Manchester Metropolitan University
TitleFormer CEO, Sanofi
TermSeptember 2019 – February 2026
Predecessor Olivier Brandicourt
Successor Belén Garijo
Children3

Paul Hudson (born 14 October 1967) [2] is a British businessman, and the former chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales. [3]

Contents

Early life

Hudson earned a degree in economics from Manchester Metropolitan University, and a diploma in marketing from the Chartered Institute of Marketing. [1]

Career

Hudson was CEO of Sanofi since September 2019. In February 2026, it was announced Hudson’s mandate would not be renewed and he will step down as CEO. [4] [5] [6]

Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca, rising to president, AstraZeneca United States and Executive Vice President, North America. [6] [7] [8]

Recognition

Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018. [1] [9]

Personal life

Hudson has three children with his wife Sandra and is an "ardent Manchester United football fan". [1]

References

  1. 1 2 3 4 "Paul Hudson - Sanofi". www.sanofi.com.
  2. ↑ "Paul Hudson - Sanofi". www.sanofi.com. Retrieved 29 January 2021.
  3. ↑ Willsher, Kim (26 January 2021). "French self-esteem hit after Pasteur Institute abandons Covid vaccine" – via www.theguardian.com.
  4. ↑ "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune.
  5. ↑ "Sanofi's CEO on a big acquisition, long-term strategy, and vaccines". 17 August 2020.
  6. 1 2 "Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership". Russell Reynolds Associates. Archived from the original on 24 February 2021. Retrieved 26 January 2021.
  7. ↑ "AstraZeneca announces changes to Senior Executive Team". Fiercepharma.
  8. ↑ "Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis". Novartis. Retrieved 24 April 2023.
  9. ↑ "Paul Hudson". Manchester Metropolitan University. Retrieved 24 April 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
霸屏SEO镜像站群 干扰字符镜像 网站离线镜像 一键镜像站群 开源整站镜像工具